| Literature DB >> 32848307 |
Soukaina El-Guendouz1, Soumia Zizi1, Youssef Elamine1, Badiaa Lyoussi1.
Abstract
BACKGROUND AND AIM: Hexavalent chromium (Cr (VI)) compounds have been shown to induce nephrotoxicity associated with oxidative stress in humans and animals. The aim of the present study was to investigate the nephroprotective effect of bee propolis, as highly antioxidant natural product, in vivo using an animal model.Entities:
Keywords: antioxidant; chromium; phenols; propolis; renal damage
Year: 2020 PMID: 32848307 PMCID: PMC7429381 DOI: 10.14202/vetworld.2020.1327-1333
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1Concentration of total phenols, flavonols, flavones, flavanones, and dihydroflavonols in propolis sample.
Figure-2Average of urinary volume excretion (UV) of control and treated rats during 10 days of treatment. The volume of 24 h urine was measured and reported as mean±standard error of the mean for six rats in each group. ♠ Chromium injection day.
Concentrations of urinary and plasma electrolyte in control and treated rats after 10 days of treatment.
| Groups | Urinary electrolyte concentration | Plasma electrolyte concentration | ||
|---|---|---|---|---|
| Na+ (mmol/L) | K+ (mmol/L) | Na+ (mmol/L) | K+ (mmol/L) | |
| Control | 75.25±1.47 | 54.6±0.75 | 141.00±0.70 | 3.1±0.81 |
| Propolis | 76.30±0.47 | 49.25±0.24 | 139.00±0.70 | 3.08±0.11 |
| Potassium dichromate | 22.02±1.01 | 7.4±0,18 | 136.00±1.41* | 7.00±0.5 |
| Propolis/potassium dichromate | 58.80±0.15* | 35.56±0,18* | 127.00±1.58* | 4.17±0.14* |
Data are presented as mean±SD, **p<0.05 compared to control, **p<0.01 compared to control,
p<0.001 compared to control. SD: Standard deviation
Figure-3Effect of propolis and potassium dichromate on creatinine clearance in normal Wistar rats treated and control. Data are presented as mean±standard deviation, **p<0.05 compared to control, **p<0.01 compared to control, ***p<0.001 compared to control.
Concentrations of biochemical parameters in control and treated rats after 10 days of treatment.
| Groups | Uosm (mosm/kgH2O) | Posm (mosm/kgH2O) | Cosm (μl/min) | CH20 (μl/min) |
|---|---|---|---|---|
| Control | 1580±9 | 286±6 | 27.62±2 | −22.6±2 |
| Propolis | 1526±9 | 278±6 | 24.7±2.2 | −20.20± |
| Potassium dichromate | 440±9 | 227±8 | 3.5±0.5 | −1.6±0.1 |
| Propolis/potassium dichromate | 1880±9 | 254±6 | 14.4±1.2 | −11.30± |
Data are presented as mean±SD,
p<0.05 compared to control, **p<0.01 compared to control,
p<0.001 compared to control. SD: Standard deviation
Effects of oral administration of propolis, potassium dichromate, propolis/potassium dichromate, and distilled water on various parameters measured (mean±SD).
| Groups | Glucose (g/L) | Triglycerides (g/L) | Cholesterol (g/L) |
|---|---|---|---|
| Control | 1.15±0.14 | 0.95±0.22 | 0.47±0.08 |
| Propolis | 0.85±0.12 | 0.75±0.11 | 0.51±0.05 |
| Potassium dichromate | 2.78±0.10 | 1.34±0.03 | 1.23±0.01 |
| Propolis/potassium dichromate | 1.81±0.16* | 1.02±0.02 | 0.61±0.12* |
p<0.05 compared to control, **p<0.01 compared to control,
p<0.001 compared to control. SD: Standard deviation